Analysis set for each outcome and definition.

<div><p>Introduction</p><p>Neurologic or immune-mediated conditions have been evaluated as potential adverse events (AEs) in coronavirus disease 2019 (COVID-19) vaccine safety surveillance. To contextualize United States (US) surveillance findings, it is important to quantify...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Shelby S. Fisher (22676406) (author)
Outros autores: Arnstein Lindaas (22676409) (author), Stella G. Muthuri (5395769) (author), Patricia C. Lloyd (18453529) (author), Joann F. Gruber (18453535) (author), Morgan M. Richey (21253213) (author), Hai Lyu (22676412) (author), Angela S. Cheng (22676415) (author), Lisa S. Kowarski (22676418) (author), Mollie M. McKillop (9111996) (author), Christine Bui (21253201) (author), Tainya C. Clarke (12892921) (author), Jeffrey Beers (22676421) (author), Timothy Burrell (12892927) (author), Pablo Freyria Duenas (22676424) (author), Yangping Chen (16549866) (author), Minya Sheng (22676427) (author), Richard A. Forshee (18453553) (author), Steven A. Anderson (11865398) (author), Yoganand Chillarige (18453556) (author), Mary S. Anthony (13922319) (author), Azadeh Shoaibi (11060528) (author), J. Bradley Layton (9756019) (author)
Publicado: 2025
Subjects:
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares